Stability of commonly used antibiotic solutions in an elastomeric infusion device

Canadian Journal of Hospital Pharmacy

Volumn 63, Issue 3, 2010, Pages 212-224

  Walker, Scott E ^a,b   Iazzetta, John ^a   Law, Shirley ^a   Biniecki, Kristof ^c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c VALEO   (France)

Author keywords

Cefazolin; Ceftazidime; Ceftriaxone; Clindamycin; Drug stability; Vancomycin

Indexed keywords

CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; ELASTOMER; POLYVINYLCHLORIDE; SILICONE; SODIUM CHLORIDE; VANCOMYCIN; WATER;

ARTICLE; DRUG DEGRADATION; DRUG STABILITY; DRUG STORAGE; INFUSION SYSTEM; LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE;

EID: 79958121554     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: 10.4212/cjhp.v63i3.917     Document Type: Article

References (31)

1. Kastango ES, Bradshaw BD. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. Am J Health Syst Pharm 2004;61(18):1928-1938. (Pubitemid 39481348)
2. Trissel LA. The new national standard for sterile preparation. Hosp Pharm 2004 Sep;39:900-904.
3. Walker SE, Hanabusa Y, Dranitsaris G, Bartle WR, Iazzetta J. Cost effective evaluation of a stability study. Can J Hosp Pharm 1987;40(4):113-118. (Pubitemid 17127974)
4. Walker SE, DeAngelis C, Iazzetta J, Gafni A. Chemotherapy waste reduction through shelf-life extension. Can J Hosp Pharm 1994;47(1):15-23. (Pubitemid 24105730)
5. Skryabina EA, Dunn TS. Disposable infusion pumps. Am J Health Syst Pharm 2006;63(13):1260-1268. (Pubitemid 44025091)
6. Walker SE, Dranitsaris G. Stability of reconstituted ceftriaxone in dextrose and saline solutions. Can J Hosp Pharm 1987;40(5):161-166.
7. Walker SE, Dranitsaris G. Stability of reconstituted ceftazidime in dextrose and saline solutions. Can J Hosp Pharm 1988;41(2):65-71.
8. Walker SE, Birkhans B. Stability of intravenous vancomycin. Can J Hosp Pharm 1988;41(5):233-238.
9. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm 1983;40(7):1159-1160.
10. Trissel LA, Flora KP. Stability studies: five years later. Am J Hosp Pharm 1988;45(7):1569-1571.
11. Policy for publication of chemical stability study manuscripts. Can J Hosp Pharm 1990;43(1):3-4.
12. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci 1992;81(3):309-312.
13. Frieman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299(13):690-694. (Pubitemid 9053296)
14. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39(5):489-490. (Pubitemid 16113119)
15. Bornstein M, Thomas PN, Coleman DL, Bylan JC. Stability of parenteral solutions of cefazolin sodium. Am J Hosp Pharm 1974;31(3):296-298.
16. Gupta VD, Stewart KR. Quantitation of carbenicillin disodium, cefazolin sodium, cephalothin sodium, nafcillin sodium, and ticarcillin disodium by high-pressure liquid chromatography. J Pharm Sci 1980;69(11):1264-1267. (Pubitemid 11162715)
17. Bosso JA, Townsend RJ. Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Am J Hosp Pharm 1985;42(10):2211-2214. (Pubitemid 15238184)
18. Allen LV Jr, Stiles ML, Prince SJ, Smeeding J. Stability of 14 drugs in the latex reservoir of an elastomeric infusion device. Am J Health Syst Pharm 1996;53(22):2740-2743. (Pubitemid 26386661)
19. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions. J Clin Pharm Ther 1996;21(3):185-189 (Pubitemid 26273778)
20. Xu QA, Trissel LA, Saenz CA, Ingram DS, Williams KY. Stability of three cephalosporin antibiotics in AutoDose Infusion System bags. J Am Pharm Assoc 2002;42(3):428-431.
21. Zbrozek AS, Marble DA, Bosso JA. Compatibility and stability of cefazolin sodium, clindamycin phosphate and gentamicin sulfate in two intravenous solutions. Drug Intell Clin Pharm 1988;22(11):873-875.
22. Das Gupta V, Bethea C, dela Torre M. Chemical stabilities of cefoperazone sodium and ceftazidime in 5% dextrose and 0,9% sodium chloride injections. J Clin Pharm Ther 1988;13(3):199-205.
23. Nahata MC. Stability of ceftriaxone sodium in intravenous solutions. Am J Hosp Pharm 1983;40(12):2193-2194.
24. Bailey LC, Tang KT, Medwick T. Stability of ceftriaxone sodium in infusion-pump syringes. Am J Hosp Pharm 1993;50(10):2092-2094. (Pubitemid 23298179)
25. Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM. Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C. Eur J Hosp Pharm Sci 2006;12(3):52-56.
26. Marble DA, Bosso JA, Townsend RJ. Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions. Am J Hosp Pharm 1986;43(7):1732-1736. (Pubitemid 16059514)
27. Holmes CJ, Ausman RK, Kundsin RB, Walter CW. Effect of freezing and micrwave thawing on the stability of six antibiotic admixtures in plastic bags. Am J Hosp Pharm 1982;39(1):104-108. (Pubitemid 12177473)
28. Porter WR, Johnson CA, Chon MS, Gillespie W. Compatibility and stability of clindamycin phosphate with intravenous fluids. Am J Hosp Pharm 1983 Jan;40:91-94. (Pubitemid 13217317)
29. Das Gupta V, Stewart KR, Nohria S. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986;43(7):1729-1731. (Pubitemid 16059513)
30. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J. Long term stability of vancomycin hydrochloride in intravenous infusions. J Clin Pharm Ther 1997;22(5):353-356. (Pubitemid 28281436)
31. Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti G. Effect of freezing, long-term storage, and microwave thawing on the stability of vancomycine hydrochloride in 5% dextrose infusions. Eur J Hosp Pharm Sci 2005;11(5):111-113.